School of Medicine

Six members of the Washington University in St. Louis community will be among the speakers at an upcoming TEDxGateway Arch event.

Researchers at Washington University School of Medicine in St. Louis have identified a pathway involved in harming rods and cones in the retina and have found a way to halt that damage.

The executive vice chancellor for medical affairs and dean of the School of Medicine, talks about his history with St. Louis, the importance of personalized medicine and how the School of Medicine can be a leader in the field.

Researchers at Washington University School of Medicine in St. Louis have shown in mice that they can inject nanoparticles into an injured joint suffering from osteoarthritis and suppress inflammation immediately following an injury, reducing the destruction of cartilage.

Washington University School of Medicine in St. Louis has received a $10 million gift to support research that harnesses the immune system to fight cancer, infectious diseases, and disorders caused by autoimmunity and immune deficiencies. The gift from Andrew M. and Jane M. Bursky will advance cutting-edge work at the newly named Andrew M. and Jane M. Bursky Center for Human Immunology and Immunotherapy Programs.

Stephanie Markovina, MD, PhD, an assistant professor of radiation oncology at the Washington University School of Medicine, has received the 2016 Junior Faculty Career Research Training Award from the American Society for Radiation Oncology. She will receive a two-year, $200,000 grant as part of the recognition.

Researchers have identified a potential way to prevent chronic urinary tract infections (UTIs). Their research points to a key protein that bacteria use to latch onto the bladder and cause UTIs, according to scientists at Washington University School of Medicine in St. Louis. Vaccinating mice against the protein reduces the ability of bacteria to cause severe disease.

A team at the School of Medicine is evaluating a new immunotherapy against acute myeloid leukemia. The treatment harnesses the immune system’s “natural killer” cells, putting them through a training period in the lab to help them attack leukemia cells in the blood.

Researchers at Washington University School of Medicine in St. Louis have found another possible explanation for some of the symptoms of fragile X syndrome. The study, published Sept. 20 in Cell Reports, provides a new way of looking at the underlying causes of the syndrome and suggests new targets for treatment.

Catherine Lang, a professor of physical therapy at Washington University School of Medicine in St. Louis, will serve a two-year term as the chairperson of the Musculoskeletal Rehabilitation Sciences Study Section, part of the National Institutes of Health (NIH) Center for Scientific Review.